India’s Vijaya Diagnostic Centre kicks off $259m IPO

Jonathan Breen

September 02, 2021 02:17 am

molecule_microscope_PA_230x150 — MOSCOW, RUSSIA - JANUARY 9, 2017: Conducting a cytogenetic testing at the Center of Molecular Diagnostics (CMD), a part of the Central Research Institute of Epidemiology of the Russian Federal Service for Supervision of Consumer Rights Protection and Human Welfare (Rospotrebnadzor). Vyacheslav Prokofyev/TASS | Vyacheslav Prokofyev/Tass/PA Images

South Indian healthcare chain floats through a secondary share offer that has already seen strong backing from anchor investors

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request demo or Login

✔ 4,000 annual insights
✔ 700+ notes and long-form analyses
✔ 4 capital markets databases
✔ Daily newsletters across markets and asset classes
✔ 2 weekly podcasts

Topics

ICICI India

JB

Jonathan Breen

Equities editor GlobalCapital Asia